Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.3191
+0.0019 (0.60%)
At close: Apr 1, 2026, 4:00 PM EDT
0.3200
+0.0009 (0.28%)
Pre-market: Apr 2, 2026, 8:07 AM EDT
Cosmos Health Revenue
Cosmos Health had revenue of $17.11M in the quarter ending September 30, 2025, with 37.86% growth. This brings the company's revenue in the last twelve months to $59.79M, up 6.69% year-over-year. In the year 2024, Cosmos Health had annual revenue of $54.43M with 1.97% growth.
Revenue (ttm)
$59.79M
Revenue Growth
+6.69%
P/S Ratio
0.19
Revenue / Employee
$401,294
Employees
149
Market Cap
11.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.43M | 1.05M | 1.97% |
| Dec 31, 2023 | 53.38M | 3.03M | 6.02% |
| Dec 31, 2022 | 50.35M | -5.89M | -10.48% |
| Dec 31, 2021 | 56.24M | 833.33K | 1.50% |
| Dec 31, 2020 | 55.41M | 15.73M | 39.65% |
| Dec 31, 2019 | 39.68M | 2.59M | 6.99% |
| Dec 31, 2018 | 37.08M | 7.07M | 23.56% |
| Dec 31, 2017 | 30.01M | 23.26M | 344.28% |
| Dec 31, 2016 | 6.76M | 6.22M | 1,165.53% |
| Dec 31, 2015 | 533.80K | -7.11M | -93.01% |
| Dec 31, 2014 | 7.64M | 6.74M | 746.55% |
| Dec 31, 2013 | 902.37K | - | - |
| Dec 31, 2012 | - | - | - |
| Jul 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 397.96B |
| Cencora | 325.78B |
| Cardinal Health | 244.67B |
| Henry Schein | 13.18B |
| Accendra Health | 2.76B |
| 111, Inc. | 1.91B |
| EDAP TMS | 70.53M |
| Synergy CHC | 34.59M |
COSM News
- 21 hours ago - Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets - Accesswire
- 13 days ago - Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions - GlobeNewsWire
- 21 days ago - Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000 - GlobeNewsWire
- 23 days ago - Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000 - GlobeNewsWire
- 5 weeks ago - Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board - GlobeNewsWire
- 5 weeks ago - Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value - GlobeNewsWire
- 6 weeks ago - Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer - GlobeNewsWire
- 6 weeks ago - Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer - GlobeNewsWire